GSK has become the first pharma company to get regulatory approval for a vaccine against respiratory syncytial virus (RSV), setting ... for approval in the EU. The regulator is due to make a ...

Learn about this vaccine that protects against a common seasonal virus that can sometimes cause severe disease, with info on ...

Fiona P. Havers, MD, MHS, spoke with Physician’s Weekly about managing RSV as a newly vaccine-preventable disease now that ...

Opens in a new tab or window The CDC recommends a single dose of any FDA-approved respiratory ... data confirmed how effective RSV vaccines were in their first season of use against ...

Moderna (MRNA.O), opens new tab said on Friday Canada's health regulator has approved its vaccine for respiratory syncytial virus in adults 60 years and older, making it the country's first ...

Arexvy, the first RSV vaccine approved in the country for this age group, is currently authorised in the US and a further 35 countries. The vaccine's active ingredient is a recombinant RSV ...